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n skeletal muscle differentiation, the retinoblastoma
protein (pRb) is absolutely necessary to establish deﬁni-
tive mitotic arrest. It is widely assumed that pRb is
equally essential to sustain the postmitotic state, but this
contention has never been tested. Here, we show that
terminal proliferation arrest is maintained in skeletal muscle
cells by a pRb-independent mechanism.
Acute Rb excision from conditional knockout myotubes
caused reexpression of E2F transcriptional activity, cyclin-E
and -A kinase activities, PCNA, DNA ligase I, RPA, and
MCM2, but did not induce DNA synthesis, showing that
I
 
pRb is not indispensable to preserve the postmitotic state
of these cells. Muscle-speciﬁc gene expression was signif-
icantly down-regulated, showing that pRb is constantly
required for optimal implementation of the muscle differ-
entiation program. Rb-deleted myotubes were efﬁciently
reactivated by forced expression of cyclin D1 and Cdk4,
indicating a functionally signiﬁcant target other than pRb
for these molecules. Finally, Rb removal induced no DNA
synthesis even in pocket-protein null cells. Thus, the post-
mitotic state of myotubes is maintained by at least two
mechanisms, one of which is pocket-protein independent.
 
Introduction
 
The defining property of terminal cell differentiation is the
permanent withdrawal from the cell cycle also known as post-
mitotic state. This state is the most typical cellular condition,
characterizing the majority of cells in adult mammals, yet too
little is known about the mechanisms underlying the irrevocable
decision to exit the cell cycle during differentiation and the
maintenance of such permanent mitotic arrest.
Early work demonstrated that the retinoblastoma protein
(pRb), a key regulator of proliferation, differentiation, and
apoptosis, is absolutely required to establish the postmitotic
state in a number of cell types, prominently including skeletal
muscle cells (Schneider et al., 1994). In the absence of pRb,
skeletal muscle cells and numerous other histotypes show
ectopic DNA synthesis and/or apoptosis, both in vitro and in
vivo (Lipinski and Jacks, 1999). Indeed, wild-type myoblasts
enter the postmitotic state before differentiating into myotubes,
whereas Rb
 
 
 
/
 
 
 
 myoblasts can only undergo nonterminal differ-
entiation, as they convert into myotubes that continue to
synthesize DNA (Novitch et al., 1996; Zacksenhaus et al., 1996).
It is widely assumed that, because pRb is essential for the
establishment of the postmitotic state, it must be also responsible
for its maintenance (Novitch et al., 1996; Lipinski and Jacks,
1999; Lowenheim et al., 1999; Mal et al., 2000; Ruiz et al., 2004).
However, this view is challenged by several observations. In
unpublished experiments, expression in terminally differentiated
(TD) myotubes of various molecules known or likely to inactivate/
counteract pRb, such as Id2, MDM2, and cytomegalovirus
IE1 and IE2, could not trigger DNA synthesis. In addition,
it has been shown that forced expression of E2F transcription
factors or active, pRb-phosphorylating Cdk2 kinase is unable
to reactivate DNA synthesis in myotubes (Puri et al., 1998;
Pajalunga et al., 1999; Latella et al., 2001). Finally, papilloma-
virus E7 is also incapable of triggering DNA synthesis in these
cells, though targeting and degrading pRb (Sacco et al., 2003).
Altogether, this evidence strongly suggests that pRb is not
responsible for the maintenance of the postmitotic state or
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that additional mechanisms protect the proliferative arrest of
these cells.
This work exploits conditional Rb knockout (KO) cells to
demonstrate that pRb contributes to but is not required for the
preservation of the postmitotic state in TD myotubes. Thus, an
additional, pRb-independent, possibly TD-cell specific mecha-
nism maintains the postmitotic state in these cells.
 
Results and discussion
 
pRb ablation does not trigger DNA 
synthesis in myotubes
 
To investigate the role of pRb in the maintenance of the post-
mitotic state in TD myotubes, we exploited Rb conditional KO
mice (Marino et al., 2000) in which pRb can be ablated via
Cre-mediated excision of loxP-flanked Rb exon 19. Myoblasts
(muscle satellite cells [MSCs]) from these mice were induced
to terminally differentiate while expressing pRb and the result-
ing myotubes were then subjected to Rb excision by infection
with a Cre recombinase-carrying adenovirus (AdCre). Fig. 1
(A–C) shows that Rb gene excision and pRb protein elimina-
tion were essentially complete 48 h after AdCre infection. In
spite of total ablation of pRb, the myotubes did not synthesize
DNA, as assessed by exposure to BrdU for up to 84 h after Ad-
Cre infection and subsequent immunodetection of BrdU incor-
poration (Fig. 1 D).
To ensure that the lack of DNA synthesis was not due to
artifacts connected with Cre expression (Loonstra et al., 2001),
Figure 1. pRb ablation in myotubes does not induce
DNA synthesis. (A) PCR of myotubes infected with a control
virus (Ctr.) or AdCre. Exon 19 denotes the amplification
product obtained from undeleted cells;   Exon 19, Exon
19 deletion; MW, 100-bp ladder (Invitrogen); PCR per-
formed as in Marino et al. (2000). (B) Western blot analysis
of pRb in control- and AdCre-infected myotubes; decreasing
amounts of total protein were loaded in the control lanes
to assess blot sensitivity. Tubulin indicates loading con-
trol. (C and D) IF analysis of myotubes infected with the
indicated viruses or derived from  Rb-MSC. 
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Rb-deleted (
 
 
 
Rb) myotubes (
 
 
 
Rb-Mt) were superinfected with
the dl520 adenovirus, carrying 12S E1A and shown previously
to reactivate the mitotic cycle in TD cells (Crescenzi et al.,
1995). E1A expression readily induced 95% of the cells to in-
corporate BrdU (Fig. 1 D), showing that 
 
 
 
Rb-Mt retained in-
tact DNA-replicating potential.
It has been demonstrated that myoblasts lacking Rb
(
 
 
 
Rb-MSC) cannot enter the postmitotic state upon differentia-
tion and continue to synthesize DNA (Schneider et al., 1994;
Novitch et al., 1996). To ensure that our experimental system
behaves accordingly, we generated 
 
 
 
Rb-MSC by infection
with AdCre. These cells were induced to differentiate for 72 h
and exposed to BrdU during the next 24 h. Double immunoflu-
orescence (IF) for muscle-specific myosin heavy chain (MyHC),
a differentiation marker, and BrdU revealed that 44.9% of the
myotubes incorporated BrdU during the indicated period, in
keeping with previous results (Fig. 1 D; Novitch et al., 1996).
Thus, in our system, Rb deletion prevents entry into the post-
mitotic state when performed before differentiation, but cannot
reactivate the cell cycle if performed in myotubes.
It has been shown recently that acute Rb deletion reacti-
vates the cell cycle in quiescent and senescent mouse embryo fi-
broblasts (MEF; Sage et al., 2003). For comparison purposes, we
isolated MEF from the Rb-loxP mice. Serum-starved, quiescent
MEF showed a fourfold increase in BrdU incorporation upon
AdCre-mediated Rb deletion (Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200408164/DC1). Thus, the com-
bined performances of our AdCre virus and of the cells derived
from the Rb-loxP mice are consistent with previous results.
We noticed that, between 72 and 96 h after AdCre infec-
tion, 
 
 
 
Rb-Mt underwent massive TUNEL-positive cell death
(unpublished data). To rule out the theoretical possibility that
cell death might temporally precede DNA synthesis and pre-
vent its occurrence, we coinfected Rb-loxP myotubes with Ad-
Cre and an adenovirus carrying the antiapoptotic Bcl-2 gene.
Expression of Bcl-2 dramatically improved cell survival, in-
creasing the number of live myotubes 96 h after infection by 5–
10-fold in several independent experiments. However, no
BrdU incorporation was observed up to 120 h after infection
(unpublished data).
Figure 2. Reactivation of cell cycle regulators
in  Rb-Mt. (A) Luciferase activity measured in
MSCs stably transfected with the control (Basic)
or E2F-responsive (6xE2F) reporter construct
and derived myotubes (Mt) infected with the
indicated viruses; data are averages of two
independent experiments, with SDs, and are
expressed as percentage of value obtained in
6xE2F-MSC. (B) DNA microarray analysis of
MSCs and myotubes infected with control or
Cre adenovirus; each line represents a distinct
mRNA; values are averages of two independent
experiments and are shown as percentages of
measurements obtained in MSCs (see Table
S1); white line indicates pRb mRNA. (C) West-
ern blot analysis of the indicated proteins in
MSCs or myotubes infected as shown, in the
presence or absence of 5% FBS; HSP70 in-
dicates loading control. (D) IF for MyHC and
cyclin A on  Rb-Mt. (E) Cyclin A and cyclin E
kinase complexes were immunoprecipitated
from MSCs or infected myotubes, reacted with
histone H1 in the presence of  -[
32P]ATP, re-
solved by gel electrophoresis, and autoradio-
graphed; Ctr. IgG indicates control-infected
myotubes immunoprecipitated with normal
rabbit IgG. 
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Altogether, these results allow us to conclude that the post-
mitotic state of myotubes is preserved by a pRb-independent
mechanism. This conclusion distinguishes TD myotubes from
quiescent and senescent cells, in which maintenance of mitotic
arrest depends on pRb (Sage et al., 2003). These data underscore
the uniqueness of the control of the cell cycle in TD myotubes
and contribute to explain their remarkable refractoriness to pro-
liferation-promoting stimuli that are otherwise powerful inducers
of cell-cycle reentry in non-TD cells (Tiainen et al., 1996).
 
Rb deletion in myotubes reactivates cell 
cycle regulators
 
Although 
 
 
 
Rb-Mt do not synthesize DNA, we investigated the
effects of pRb deletion at the biochemical level. First, the trans-
acting activity of the Rb-modulated E2F family of transcription
factors was studied using an E2F reporter construct. Fig. 2 A
shows that E2F transcriptional activity, readily measurable in
MSCs, was much reduced in myotubes. Strikingly, Rb deletion
brought this activity back to MSC levels. To determine whether
the E2F activity detected in myotubes is effective on endoge-
nous, S phase–promoting, E2F-target genes, cRNA from our
cells was hybridized with DNA oligonucleotide arrays. Only
small parts of these results are shown here, whereas the microar-
ray experiments will be described in full elsewhere. We looked
at genes shown to be E2F regulated by a previous microarray
study of murine fibroblasts (Ishida et al., 2001). Fig. 2 B shows
normalized expression values of all E2F targets that could be
unambiguously identified in our microarrays as coincident with
those of Ishida et al. (2001) and yielded meaningful signals in
our experiments (see Materials and methods and Table S1,
available at http://www.jcb.org/cgi/content/full/jcb.200408164/
DC1). In agreement with the results obtained using the E2F re-
porter construct, most E2F-regulated genes (26 of 28) showed
decreased expression in TD myotubes, but their expression lev-
els significantly increased upon Rb excision. Thus, pRb ablation
in myotubes brings about reactivation of E2F transcription fac-
tors and enhanced expression of their target genes.
Next, we assessed the expression of G1 cyclins regulating
the G1/S phase transition. Fig. 2 C shows that the cyclin E and
A proteins, normally expressed in the proximity of the G1/S
transition, are up-regulated in 
 
 
 
Rb-Mt to levels similar to those
found in MSCs, consistent with their genes being E2F targets
(Ishida et al., 2001). Conversely, expression of cyclin D1 pro-
tein, a cyclin exerting its action at earlier times in G1 phase, was
not increased by pRb ablation. Fig. 2 D shows that cyclin A was
properly localized to the nuclei of 
 
 
 
Rb-Mt, ruling out the possi-
bility that it is inactive with respect to DNA synthesis due to de-
localization. In addition, Fig. 2 E shows that in 
 
 
 
Rb-Mt, cyclin
E– and A–associated kinase activities were higher than in
MSCs, a finding at least partially explained by the comparison
of de facto synchronized myotubes with asynchronous MSCs.
Finally, Rb deletion brought the expression of DNA repli-
cation effector proteins, such as PCNA, MCM2, DNA ligase I,
and replication protein A, back to MSC levels (Fig. 3 A). Be-
cause the levels of PCNA and DNA ligase I increased in 
 
 
 
Rb-
Mt, we investigated their subnuclear distribution pattern as a
means to distinguish nuclei that are in early, mid, and late S phase
(Hozak et al., 1994; Montecucco et al., 1995). The majority of
 
 
 
Rb-Mt displayed evenly distributed, fine, punctate PCNA (Fig.
3 B) and DNA ligase I (unpublished data) pattern throughout
their nucleoplasms, suggesting an arrest at the G1/S boundary.
These results show that pRb removal activates molecular
events usually associated with transition into S phase, indicat-
ing that pRb does act in myotubes as a barrier to S phase entry.
However, as demonstrated in the preceding paragraph, a sec-
ond, pRb-independent mechanism prevents DNA synthesis
from taking place and arrests 
 
 
 
Rb-Mt in a state best described
as accumulation at the G1/S transition.
 
The constant presence of pRb is 
necessary for optimal skeletal muscle 
gene expression
 
It has been shown that pRb is necessary in the course of differ-
entiation for the full expression of a subset of muscle genes
(Novitch et al., 1999). One view is that pRb facilitates such ex-
pression by contributing to chromatin remodeling, which might
be accomplished once and forever at the onset of terminal dif-
ferentiation. Hence, pRb might become dispensable once its re-
Figure 3. Reactivation of DNA synthesis effectors in  Rb-Mt. (A) Western blot
analysis of the indicated proteins in MSCs and infected myotubes. (B) Con-
focal microscopy of PCNA and BrdU IF in myotubes infected as indicated. 
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modeling function has been performed. Thus, we asked whether
pRb is still required for full muscle gene expression after the
establishment of differentiation. To address this question, we
interrogated again the microarray data described above. Ex-
pression of a number of muscle-specific genes was compared
in 
 
 
 
Rb-Mt versus control-infected myotubes. These genes
showed reductions in expression ranging from 66 to 15%
(Table S2, available at http://www.jcb.org/cgi/content/full/jcb.
200408164/DC1) already 48 h after AdCre infection, which
probably underestimates the true extent of gene down-regula-
tion due to variable persistence of the different mRNAs.
Thus, although pRb is not necessary to maintain the post-
mitotic state, its continuous presence is required for full expres-
sion of tissue-specific genes.
 
The pRb-independent block to DNA 
synthesis can be relieved by cyclin D1/
Cdk4
 
We have shown previously that cyclin D1 and Cdk4 coexpres-
sion can reactivate DNA synthesis in TD myotubes (Latella et
al., 2001). Because pRb is the most important target of cyclin
D, we asked whether the latter would still be able to reactivate
the cell cycle in 
 
 
 
Rb-Mt. Therefore, we superinfected 
 
 
 
Rb-Mt
with adenoviruses expressing cyclin D1 and Cdk4. Fig. 4 A
shows that a subthreshold infection with these viruses, unable
to reactivate DNA synthesis in pRb-expressing myotubes, effi-
ciently induced DNA synthesis in 70% of 
 
 
 
Rb-Mt.
Thus, the pRb-independent block to DNA synthesis of
TD myotubes is cyclin D1/Cdk4 inactivatable. In addition,
these results indicate that at least one significant nonpRb target
for these proteins exists in TD myotubes.
 
The second block of myotubes is pocket-
protein independent
 
It has been shown that, in the absence of pRb, myotubes as well
as other cell types express high levels of the pRb-family pro-
tein p107 which has been proposed to partially substitute for
pRb (Schneider et al., 1994). Western blot analysis of 
 
 
 
Rb-Mt
confirmed that p107 protein levels are promptly increased upon
pRb removal, whereas expression of the other pRb-family pro-
tein, p130 remains essentially unchanged (Fig. 4 B). Because
all pRb-family members, referred to as “pocket” proteins, are
substrates of cyclin D–associated kinases (Xiao et al., 1996;
Farkas et al., 2002; Leng et al., 2002), p107 and/or p130 might
conceivably be responsible for the pRb-independent block ob-
served in myotubes and this activity might be removed by
Cdk4-mediated phosphorylation. However, several lines of ev-
idence indicate that this is not the case. First, p107/p130 double
KO mice show no muscle phenotype (Cobrinik et al., 1996).
Second, attempts to curb p107 expression through high serum
Figure 4. Roles of cyclin D1 and pocket proteins in
controlling the postmitotic state. (A) BrdU incorporation in
myotubes infected as indicated. (B) Western blot analysis
of p107 and p130 in MSCs and infected myotubes. (C)
Schematic of the generation of TKO myotubes. (D) Myotubes
derived from TKO MEF infected with a control retrovirus
(Bbxp) or from two independent populations infected with
a retrovirus carrying a Cre-excisable Rb (Rb1 and Rb2)
were treated with AdCre or a control adenovirus. Total
proteins were extracted and Western blot analyzed. (E)
Analysis of BrdU incorporation in the same myotube pop-
ulations as in D. The results are averages and SDs of
three independent experiments and are shown as the
ratio of BrdU
  myotubes in Cre-infected (Rb
 ) over control-
infected (Rb
 ) populations. 
JCB • VOLUME 167 • NUMBER 3 • 2004 422
 
treatment (Schneider et al., 1994) in 
 
 
 
Rb-Mt significantly re-
duced p107 levels but induced no DNA synthesis (unpublished
data). Third, expression of HPV E7 in myotubes presumably
inactivates all three pRb family members, but cannot induce
DNA synthesis (Sacco et al., 2003). Finally, E2F transcrip-
tional activity is fully reactivated in 
 
 
 
Rb-Mt, showing that the
two sister proteins cannot replace the fundamental E2F-
repressing activity of pRb in this setting (Fig. 2, A and B).
These arguments notwithstanding, the potential vicarious role
of p107/p130 in the maintenance of the postmitotic state was
addressed directly by performing Rb deletion in cells devoid of
its sister proteins.
As schematically shown in Fig. 4 C, MEF from mice in
which the three Rb-family genes have been targeted (triple KO,
TKO; Sage et al., 2000) were infected with a retrovirus ex-
pressing a floxed Rb cDNA or the Bbxp control retrovirus. Ph-
leomycin-selected, polyclonal populations were then converted
into muscle cells by expressing the muscle-regulatory gene
MyoD and induced to differentiate. Myotubes developed
within 3 d in both the pRb-expressing and control populations.
These myotubes were then infected with AdCre or control ade-
novirus and DNA synthesis was assessed by double IF for
MyHC and BrdU. Although populations homogeneously ex-
pressing pRb could not be obtained, in three independent ex-
periments, each performed with two distinct pRb-transduced
cell lines, the number of BrdU
 
 
 
 myotubes increased from 39.3 
 
 
 
6.6% (Rb
 
 
 
) to 61.8 
 
 
 
 12.2% (Rb
 
 
 
) (average 
 
 
 
 SD), indicating
that exogenous Rb effectively allowed a significant fraction of
cells to reach the postmitotic state. Subsequent infections of the
myotubes with AdCre eliminated pRb (Fig. 4 D), but resulted
in no significant reduction in the number of BrdU
 
 
 
 myotubes
(Fig. 4 E). This experiment shows that pRb can establish the
postmitotic state even in the absence of its sister proteins. More
important, it shows that deletion of pRb from fully differenti-
ated myotubes does not trigger DNA synthesis even in a
pocket-protein null background. We conclude that the newly
identified mechanism preventing DNA replication in TD myo-
tubes is pocket-protein independent.
The results summarized in this paper unveil a previously
unsuspected pocket-protein independent block prohibiting TD
myotubes entry into S phase, setting apart TD myotubes from
quiescent and senescent cells, whose proliferation arrest criti-
cally depends on pRb (Sage et al., 2003). Whether this block is
common to other TD cell types remains to be investigated. We
note, however, that in one study functional ablation of the pRb
family caused apotosis in cortical neuronal precursors but no
phenotype in TD neurons (Slack et al., 1998). This supports the
notion that pRb plays different roles before and after the onset
of terminal differentiation in other histotypes.
The finding that cyclin D1 and Cdk4 can suppress the
newly discovered block is also important. Genetic evidence in-
dicates that the only critical substrate of the cyclin D–associ-
ated kinase is pRb (Lukas et al., 1995; Medema et al., 1995),
although a few additional targets have been found (Matsuura et
al., 2004). However, cyclin D1 is also involved in regulatory
activities independent of its Cdk-regulating function (Zwijsen
et al., 1997; Cheng et al., 1998) and we do not know whether
unlocking the pRb-independent block requires Cdk4 kinase ac-
tivity. This issue deserves further investigation.
 
Materials and methods
 
Antibodies
 
Antibodies used in IF: BrdU: clone Bu20a (DakoCytomation) or Alexa Fluor
488 conjugate (Molecular Probes); cyclin A: C-19; PCNA: PC10 (Santa
Cruz Biotechnology, Inc.); MyHC: rabbit polyclonal (a gift from G. Cossu,
Scientific Institute San Raffaele, Milan, Italy). Secondary antibodies were
purchased from Molecular Probes. Nuclei were counterstained with Hoechst
33258. Where indicated, confocal microscopy was performed with TCS
SP2 digital scanning instrument (Leica). Western blotting: pRb, clone G3-
245 (BD Biosciences); p107, clone SD9; p130, C-20; cycD1, M-20; cycA,
C-19; cycE, M-20; PCNA, PC10; MCM2, N-19 (Santa Cruz Biotechnol-
ogy, Inc.); RPA70, 2H10 (NeoMarkers); DNA ligase I, 5H5 (Areta Interna-
tional); 
 
 
 
-tubulin, clone 2-28-33 (Sigma-Aldrich); and HSP70, N27F3-4
(StressGen). Detection was performed with HRP-conjugated secondary anti-
bodies (Cappel) and West Dura kit (Pierce Chemical Co.).
 
Cells and viruses
 
MSC isolation and culture have been described previously (Tiainen et al.,
1996). To obtain myotubes, MSCs were plated on gelatin-coated dishes
in DME containing 10% FBS and 12 h later switched to 5% horse serum.
After 72 h, myotubes were infected with either control or AdCre virus at
multiplicity of infection (m.o.i.) 1,000. The dl520, cyclin D1–, and Cdk4-
expressing adenoviruses (Latella et al., 2001) were used at m.o.i. 300,
40, and 500, respectively. In multiple infections, AdCre was used first fol-
lowed, 24 h later, by dl520 or cycD1/Cdk4. Unless otherwise stated,
myotubes were treated with 10% FBS (with 20 
 
 
 
M BrdU if required) start-
ing 24 h after infection and fixed for IF or harvested for biochemical pro-
cedures 24 h later.
 
Luciferase reporter assays
 
MSCs were transfected with the pGL3TATAbasic or pGL3TATA6xE2F re-
porter construct and selected in 2 
 
 
 
g/ml puromycin. Stable polyclonal
MSCs were infected after differentiation as described above. Lucifer-
ase activity was measured with the Bright-Glo Luciferase Assay System
(Promega).
 
DNA microarrays
 
Total mRNA was converted into cDNA and then biotin-labeled cRNA us-
ing the SuperScript II (Invitrogen) and ENZO (Affymetrix) kits. cRNAs were
hybridized to MGU74Av2 oligonucleotide microarrays (Affymetrix) ac-
cording to manufacturer’s instructions. Data analysis was performed using
Affymetrix Microarray Suite v.5.0 and Microsoft Excel.
 
Kinase assays
 
Immunoprecipitation of cyclin-associated kinase activity (Pajalunga et al.,
1999) was performed using antibodies to cycA (H-432) or cycE (M-20)
(Santa Cruz Biotechnology, Inc.).
 
Generation of TKO myotubes
 
To stably express an excisable pRb in TKO MEF, a LoxP site was intro-
duced in the pBabeBleo (Morgenstern and Land, 1990) 3
 
 
 
 LTR as de-
scribed previously (Berghella et al., 1999), obtaining pBbxp. An HA-
tagged Rb cDNA (a gift from P. Amati, European Institute of Oncology,
Milan, Italy) was inserted into the EcoRI and SalI sites, obtaining pBbxp/
HA-Rb. Control and Rb-expressing retroviruses, produced in Phoenix cells,
were used to generate phleomicin-resistant TKO MEF polyclonal popula-
tions. These cells were infected with a MyoD adenovirus (m.o.i. 750) and
induced to differentiate in serum-free medium for 72 h. Myotubes were in-
fected as described above and assayed for BrdU incorporation.
 
Online supplemental material
 
Fig. S1 shows that pRb ablation can reactivate the cell cycle in quiescent
MEFs. pRb immunoblot confirmed pRb removal from Cre-infected fibro-
blasts (A), which increasingly incorporated BrdU in the next 96 h (B). Ta-
ble S1 shows increased accumulation of mRNAs of unselected E2F target
genes upon pRb removal in myotubes, as measured by DNA microarray
analysis. Table S2 shows decreased expression of mRNAs of muscle-
specific genes after AdCre infection of myotubes. Online supplemental
material is available at http://www.jcb.org/cgi/content/full/jcb.
200408164/DC1. 
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